On January 17, BROADWOOD PARTNERS LP, 10% Owner at Staar Surgical STAA executed a significant insider buy, as disclosed in the latest SEC filing.
On January 17, BROADWOOD PARTNERS LP, 10% Owner at Staar Surgical (NASDAQ:STAA) executed a significant insider buy, as disclosed in the latest SEC filing. What Happened: In a recent Form 4 filing ...
LAKE FOREST, Calif., January 13, 2025--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLâ„¢) for vision ...
The transactions highlight Broadwood Partners' continued confidence in STAAR Surgical (NASDAQ:STAA), a company known for its ophthalmic goods. Neal C. Bradsher, President of Broadwood Capital, Inc ...
The transactions highlight Broadwood Partners' continued confidence in STAAR Surgical (NASDAQ:STAA), a company known for its ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.